Olema Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 7.47 M | $43.55 M | 100.00% | 13.05% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 7.30 M | $42.59 M | 32.73% | 12.76% |
| BVF INC/IL | 02/14/2025 | 5.72 M | $33.32 M | -37.43% | 9.98% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.79 M | $22.09 M | -1.50% | 6.62% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 3.67 M | $21.40 M | -0.45% | 6.41% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 3.44 M | $20.07 M | -13.93% | 6.01% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 3.21 M | $18.71 M | 0.00% | 5.60% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 2.91 M | $16.98 M | 8.65% | 5.09% |
| VANGUARD GROUP INC | 02/11/2025 | 2.69 M | $15.65 M | 6.01% | 4.69% |
| 02/14/2025 | 1.93 M | $11.26 M | 100.00% | 3.37% | |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.88 M | $10.98 M | 12.95% | 3.29% |
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 1.65 M | $9.63 M | 100.00% | 2.88% |
| CANDRIAM S.C.A. | 02/07/2025 | 1.55 M | $9.05 M | 2.97% | 2.71% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 1.53 M | $8.84 M | 52.14% | 2.66% |
| VIVO CAPITAL, LLC | 02/13/2025 | 1.51 M | $8.78 M | 0.00% | 2.63% |
| WOODLINE PARTNERS LP | 02/14/2025 | 1.36 M | $7.91 M | 0.24% | 2.37% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.33 M | $7.77 M | -3.21% | 2.33% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 1.13 M | $6.57 M | 59.02% | 1.97% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 979,219 | $5.71 M | 1,154.44% | 1.71% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 926,162 | $5.40 M | -0.94% | 1.62% |
| 02/14/2025 | 650,000 | $3.79 M | 100.00% | 1.14% | |
| UBS GROUP AG | 02/14/2025 | 560,506 | $3.27 M | 622.80% | 0.98% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 533,111 | $2.99 M | 548.66% | 0.93% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 505,400 | $2.95 M | 9.41% | 0.88% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 449,698 | $2.62 M | -2.90% | 0.79% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 382,917 | $2.23 M | -17.18% | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 365,198 | $2.13 M | -8.70% | 0.64% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 332,950 | $1.94 M | 0.66% | 0.58% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 313,982 | $1.83 M | 77.73% | 0.55% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 273,706 | $1.60 M | 1,714.91% | 0.48% |
| PIER CAPITAL, LLC | 02/11/2025 | 272,372 | $1.59 M | 100.00% | 0.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 233,281 | $1.36 M | -48.74% | 0.41% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 220,264 | $1.28 M | 100.00% | 0.38% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 01/15/2025 | 212,246 | $1.24 M | 80.49% | 0.37% |
| HIGHVISTA STRATEGIES LLC | 02/14/2025 | 212,185 | $1.24 M | 0.00% | 0.37% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 193,748 | $1.13 M | 100.00% | 0.34% |
| MARSHALL WACE, LLP | 02/13/2025 | 192,943 | $1.12 M | -19.74% | 0.34% |
| JPMORGAN CHASE & CO | 02/12/2025 | 160,751 | $937,178 | -11.20% | 0.28% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 157,300 | $917,059 | 435.03% | 0.27% |
| NEWTYN MANAGEMENT, LLC | 02/14/2025 | 140,000 | $816,200 | 0.00% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 128,666 | $750,123 | -2.66% | 0.22% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 118,434 | $690,470 | 0.00% | 0.21% |
| BARCLAYS PLC | 02/13/2025 | 114,879 | $669,000 | 21.03% | 0.20% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 93,979 | $547,898 | 23.70% | 0.16% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 93,100 | $542,773 | -89.07% | 0.16% |
| DANA INVESTMENT ADVISORS, INC. | 02/06/2025 | 92,039 | $536,587 | 7.26% | 0.16% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 91,994 | $536,324 | -0.01% | 0.16% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 91,298 | $532,000 | 30.72% | 0.16% |
| ALLOSTERY INVESTMENTS LP | 02/14/2025 | 90,000 | $524,700 | 100.00% | 0.16% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 89,000 | $518,870 | -12.06% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Olema Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 163 institutional investors and hedge funds held shares of Olema Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Bain Capital Life Sciences Investors, LLC: 7.47 M
Paradigm Biocapital Advisors LP: 7.3 M
BVF INC/IL: 5.72 M
BlackRock Funding, Inc. /DE: 3.79 M
Point72 Asset Management, L.P.: 3.67 M
Deep Track Capital, LP: 3.44 M
124.48% of Olema Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 70.86 M shares in the last 24 months. This purchase volume represents approximately $389.71 M in transactions.